v3.26.1
SCHEDULE OF REVISION ON THE PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net $ 47,281,085   $ 49,018,882   $ 97,444,041 $ 99,906,781
Gross profit 41,996,762   42,180,179   86,234,219 84,931,617
Operating income (loss) (7,129,601)   (2,346,886)   (16,058,673) (3,528,603)
Net income (loss) (7,083,941) $ (8,872,596) (1,114,589) $ 348,067 (15,956,537) (766,522)
Net loss attributable to LifeMD, Inc. (7,083,941)   (1,619,664)   (15,956,537) (1,803,442)
Net loss attributable to LifeMD, Inc. common stockholders $ (7,860,503)   $ (2,396,226)   $ (17,509,662) $ (3,356,567)
Basic loss per share attributable to LifeMD, Inc. common stockholders $ (0.16)   $ (0.05)   $ (0.37) $ (0.08)
Diluted loss per share attributable to LifeMD, Inc. common stockholders $ (0.16)   $ (0.05)   $ (0.37) $ (0.08)
Non-controlling interest $ (7,966,455) (15,036,846) $ 4,239,744 5,470,088 $ (7,966,455) $ 4,239,744
Accounts receivable         (1,950,881) 1,513,946
Deferred revenue         (16,552) (2,586,163)
Accrued expenses         987,170 (5,260,493)
Net cash provided by operating activities         (6,481,023) 11,707,834
Retained Earnings [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Net income (loss) (7,083,941) (8,872,596) (1,619,664) (183,778)    
Non-controlling interest $ 246,112,737 $ 238,252,234 243,207,498 240,811,272 $ 246,112,737 243,207,498
Noncontrolling Interest [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Net income (loss)     505,075 531,845    
Non-controlling interest     (2,253,895) $ (2,024,939)   (2,253,895)
Telehealth Revenue [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     49,018,882     99,906,781
Previously Reported [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     62,218,185     127,915,941
Gross profit     54,787,281     111,841,321
Operating income (loss)     (906,772)     1,636,152
Net income (loss)     (1,569,799)     346,850
Net loss attributable to LifeMD, Inc.     (2,074,874)     (690,070)
Net loss attributable to LifeMD, Inc. common stockholders     $ (2,851,436)     $ (2,243,195)
Basic loss per share attributable to LifeMD, Inc. common stockholders     $ (0.06)     $ (0.05)
Diluted loss per share attributable to LifeMD, Inc. common stockholders     $ (0.06)     $ (0.05)
Accounts receivable           $ 887,684
Deferred revenue           (2,690,893)
Accrued expenses           (5,865,264)
Net cash provided by operating activities           11,707,834
Previously Reported [Member] | Retained Earnings [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     $ 238,496,413     238,496,413
Previously Reported [Member] | Noncontrolling Interest [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     (2,164,934)     (2,164,934)
Previously Reported [Member] | Telehealth Revenue [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     48,563,672     101,020,153
Revision of Prior Period, Reclassification, Adjustment [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     455,210     (1,113,372)
Gross profit     455,210     (1,113,372)
Operating income (loss)     455,210     (1,113,372)
Net income (loss)     455,210     (1,113,372)
Net loss attributable to LifeMD, Inc.     455,210     (1,113,372)
Net loss attributable to LifeMD, Inc. common stockholders     $ 455,210     $ (1,113,372)
Basic loss per share attributable to LifeMD, Inc. common stockholders     $ 0.01     $ (0.03)
Diluted loss per share attributable to LifeMD, Inc. common stockholders     $ 0.01     $ (0.03)
Accounts receivable           $ 645,683
Deferred revenue           (32,312)
Accrued expenses           500,000
Net cash provided by operating activities          
Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     $ 4,711,085     4,711,085
Revision of Prior Period, Reclassification, Adjustment [Member] | Noncontrolling Interest [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     (88,961)     (88,961)
Revision of Prior Period, Reclassification, Adjustment [Member] | Telehealth Revenue [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     455,210     (1,113,372)
As Revised [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     62,673,395     126,802,569
Gross profit     55,242,491     110,727,949
Operating income (loss)     (451,562)     522,780
Net income (loss)     (1,114,589)     (766,522)
Net loss attributable to LifeMD, Inc.     (1,619,664)     (1,803,442)
Net loss attributable to LifeMD, Inc. common stockholders     $ (2,396,226)     $ (3,356,567)
Basic loss per share attributable to LifeMD, Inc. common stockholders     $ (0.05)     $ (0.08)
Diluted loss per share attributable to LifeMD, Inc. common stockholders     $ (0.05)     $ (0.08)
Accounts receivable           $ 1,533,367
Deferred revenue           (2,723,205)
Accrued expenses           (5,365,264)
Net cash provided by operating activities           11,707,834
As Revised [Member] | Retained Earnings [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     $ 243,207,498     243,207,498
As Revised [Member] | Noncontrolling Interest [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest     (2,253,895)     (2,253,895)
As Revised [Member] | Telehealth Revenue [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     49,018,882     99,906,781
Discontinued Operations [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net     13,654,513     26,895,788
Gross profit     13,062,312     25,796,332
Operating income (loss)     1,895,324     4,051,383
Net income (loss)        
Net loss attributable to LifeMD, Inc.        
Net loss attributable to LifeMD, Inc. common stockholders        
Basic loss per share attributable to LifeMD, Inc. common stockholders        
Diluted loss per share attributable to LifeMD, Inc. common stockholders        
Accounts receivable           $ 19,421
Deferred revenue           (137,042)
Accrued expenses           (104,771)
Net cash provided by operating activities          
Discontinued Operations [Member] | Retained Earnings [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest        
Discontinued Operations [Member] | Noncontrolling Interest [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Non-controlling interest        
Discontinued Operations [Member] | Telehealth Revenue [Member]            
New Accounting Pronouncements or Change in Accounting Principle [Line Items]            
Total revenues, net